Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for Auxilium Pharmaceuticals, Inc. > News item |
Auxilium Pharmaceuticals files $100 million shelf
By Angela McDaniels
Seattle, April 21 - Auxilium Pharmaceuticals, Inc. registered to sell up to $100 million of securities in a S-3 filing with the Securities and Exchange Commission.
Covered by the shelf are common stock, preferred stock, debt securities and warrants. Preferred stock and debt securities may be structured as convertibles.
Proceeds will be used for general corporate purposes, including debt repayment, future acquisitions, capital expenditures and working capital.
Auxilium is a pharmaceutical company based in Malvern, Pa., that develops urology and sexual health products.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.